Commentary MICKEY MAURER: No more stock advice-I promise
“At $2.94 per share, the price of Finish Line stock has almost fully discounted the downside risk.” Whew! The above quote in my column of Dec. 3, 2007, had me choking on my own ink. I was addressing Finish Line’s ill-fated quest to purchase the outstanding stock of much larger Genesco Inc. for $54.50 a share. The thought of trying to digest the $1.5 billion purchase price is reminiscent of Charlie Chaplin’s lunching on his own boots. I predicted that…